Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial.

Tools

COLLINS, Karen, REED, Malcolm, LIFFORD, Kate, BURTON, Maria, EDWARDS, Adrian, RING, Alistair, BRAIN, Katherine, HARDER, Helena, ROBINSON, Thompson, CHEUNG, Kwok Leung, MORGAN, Jenna, AUDISIO, Riccardo, WARD, Susan, RICHARDS, Paul, MARTIN, Charlene, CHATER, Tim, PEMBERTON, Kirsty, NETTLESHIP, Anthony, MURRAY, Christopher, WALTERS, Stephen, BORTOLAMI, Oscar, ARMITAGE, Fiona, LEONARD, Robert, GATH, Jacqui, REVELL, Deirdre, GREEN, Tracy and WYLD, Lynda (2017). Bridging the age gap in breast cancer: evaluation of decision support interventions for older women with operable breast cancer: protocol for a cluster randomised controlled trial. BMJ open, 7 (7), e015133. [Article]

[+][-]

Documents

16510:217542
16510:238921

[+][-]

16510:217542

[thumbnail of Collins - Bridging the age gap in breast cancer (VoR).pdf]

Preview

PDF
Collins - Bridging the age gap in breast cancer (VoR).pdf - Published Version
Available under License Creative Commons Attribution.

Download (628kB) | Preview

16510:238921

[thumbnail of Collins - Evaluation of decision support interventions for older women with operable breat - BMJ (AM).pdf]

Preview

PDF
Collins - Evaluation of decision support interventions for older women with operable breat - BMJ (AM).pdf - Accepted Version
Available under License Creative Commons Attribution.

Download (124kB) | Preview

Abstract

While breast cancer outcomes are improving steadily in younger women due to advances in screening and improved therapies, there has been little change in outcomes among the older age group. It is inevitable that comorbidities/frailty rates are higher, which may increase the risks of some breast cancer treatments such as surgery and chemotherapy, many older women are healthy and may benefit from their use. Adjusting treatment regimens appropriately for age/comorbidity/frailty is variable and largely non-evidence based, specifically with regard to rates of surgery for operable oestrogen receptor-positive disease and rates of chemotherapy for high-risk disease. This multicentre, parallel group, pragmatic cluster randomised controlled trial (RCT) (2015-18) reported here is nested within a larger ongoing 'Age Gap Cohort Study' (2012-18RP-PG-1209-10071), aims to evaluate the effectiveness of a complex intervention of decision support interventions to assist in the treatment decision making for early breast cancer in older women. The interventions include two patient decision aids (primary endocrine therapy vs surgery/antioestrogen therapy and chemotherapy vs no chemotherapy) and a clinical treatment outcomes algorithm for clinicians. National and local ethics committee approval was obtained for all UK participating sites. Results from the trial will be submitted for publication in international peer-reviewed scientific journals. 115550. European Union Drug Regulating Authorities Clinical Trials (EudraCT) number 2015-004220-61;Pre-results. Sponsor's Protocol Code Number Sheffield Teaching Hospitals STH17086. ISRCTN 32447*. [Abstract copyright: © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.]

More Information

Official URL:

http://bmjopen.bmj.com/content/7/7/e015133

Additional Information:

** From PubMed via Jisc Publications Router.

Uncontrolled Keywords:

Breast cancer, chemotherapy, decision aid, elderly, primary endocrine therapy, surgery

Research Institute, Centre or Group - Does NOT include content added after October 2018:

Centre for Health and Social Care Research

Page Range:

e015133

Identifiers